A new glycopeptide antibiotic complex was isolated from the fermentation culture of Kibdelosporangium aridum subsp. largum (SK&F AAD-609) by affinity chromatography on a D-alanyl-D-alanine agarose column. The major components of the complex were resolved by preparative reversed-phase HPLC. Mild acid hydrolysis showed that the new antibiotics have the same mannosyl aglycon (2) as the aridicins.
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and Haas) without a prior acid precipitation step. The 64 liters of XAD-7 eluate was coned to 4.5 liters for further purification and the product yield quantified by HPLC assay. The cells were extracted with 80 liters of MeOH at room temp, the extract concd to 20 liters at 32°C in a rising film evaporator and then further reduced to 8.25 liters by rotary evaporation. The concentrate was centrifuged at 4°C for 60 minutes at 3,000 x g and the supernatant (7 liters) filtered through Whatman Number 1 filter paper using precoat filter aid (Hyflo Supercel, Johns-Mansville Products Corporation).
Affinity Chromatography
The coned XAD-7 eluate was adjusted to pH 7 with 2 N HCl and filtered through Whatman Number 1 filter paper using the filter aid. The filtrate was combined with 600 ml of Affi-gel 10 -DAla-D-Ala (maximum loading capacity, 12 mg/ml)4) for 30 minutes in a batch-type procedure, the slurry poured into a 4.5 x 60 cm glass column fitted with a filter disk and stopcock and the spent collected. The gel was washed with 6 liters of 0.02 M sodium phosphate at pH 7 followed by 3 liters of 0.5 M NH4OAc at pH 7.8. The aridicin complex was specifically eluted using a 5%. acetonitrile -H2O prewash followed by elution of the novel kibdelins with 50% acetonitrile in 0.1 M ammonia. One liter fractions were collected and assayed by HPLC. Fractions containing the novel glycopeptide antibiotics were pooled and lyophilized to dryness. Following column regeneration with 2 liters of 30% acetonitrile in 0.4 M sodium carbonate at pH 9.5, the spent material was recycled. Glycopeptide products were purified from the 7 liters of MeOH cell extract as described above with the exception of washing the Affi-gel with 6 liters of 10 % MeOH -H2O prior to product elution.
Preparative Reversed-phase Chromatography The individual components of the aridicin complex were resolved by HPLC according to the procedure developed by SITRIN et a1.51 using a 22 mm x 30 cm prepacked Whatman Magnum-20 10 micron Partisil ODS-3 column equipped with a Beckman 112 preparative pump and ISCO V4 variable wavelength detector. The chromatography was performed at a flow rate of 15 ml/minute while monitoring the eluate at 300 nm and collecting 25-ml fractions. The sample load was approximately 140 mg dissolved in 15 % acetonitrile in 0.1 M phosphate, pH 6. The step-wise acetonitrile gradient was modified to 28 to 32%. acetonitrile in 0.1 M potassium phosphate at pH 6. The isolated components were desalted on XAD-7 and lyophilized to dryness for further analysis. 
General Procedures
Isoelectric focussing was performed as described elsewhere10) using an LKB Multiphor apparatus and activity against Bacillus subtilis as detection. Carbohydrate analysis, potentiometric titration, thermogravimetric analysis and IR and UV spectroscopy were as described5) with the following additions. Characterization of the carbohydrates was by GC/CI-MS of mannose and glucosamine as their alditol acetates using ammonia as the reagent gas and a column temperature programmed from 125°C to 310°C at 10°C/minute. FAB-MS spectrometry was carried out as described earlier11).
Identification of the Pseudoaglycon Solid samples of antibiotics were dissolved in 0.1 M sodium phosphate, adjusted to pH 3.2 at a concentration of 0.2 mg/ml and then heated to 100°C for 15 hours in a sealed vacuum hydrolysis tube. Hydrolysis products were initially identified as the aglycon of the aridicin complex by co-injection with an authentic sample by HPLC. Confirmation of the identity of the mannosyl aglycon was obtained by comparison of the sample FAB-MS with that of the standard.
Lipid Determination
Fatty acid methyl esters were prepared as previously described 12) and analysis was carried out using a Finnigan 3265 GC-MS operating in the chemical ionization (CI) mode.
Separation was achieved using a DB-17 fused silica capillary column (15 m x O.25 mm) programmed from 80°250°C at 10°C/minute with either methane or dimethyl ether (DME)* as the reagent gas.
Controlled Methanolysis of Kibdelin D to Glycolipids 2 and 3 A 220-mg sample of kibdelin D (previously dried over P205 under vacuum for 24 hours) was dissolved in 40 ml of 0.1 N HCl -MeOH and heated at 105°C for 1 hour in a sealed tube. The solution was adjusted to pH 7 with 5 % Na2CO3, the solvent removed by rotary evaporation and the white residue redissolved in 10 ml of 15 % acetonitrile -H2O. The sample was initially fractionated by reversed-phase HPLC on a Whatman Magnum 9 ODS-3 column (9.4 mm x 50 cm) in an aqueous mobile phase containing 37 % acetonitrile in 0.05 % TFA at a flow rate of 5 ml/minute. The material was further purified on a 2.5 x 25 cm column of Whatman Partisil ODS-3 media using an aqueous mobile phase of 40% acetonitrile at a flow rate of 15 ml/minute. This yielded two products 2 (18.6 mg) and 3 (6.5 mg). * DME was used as a CI reagent gas because it has the unique ability to differentiate branched from normal fatty acid methyl esters. With DME, only branched fatty acid methyl esters exhibit intense (M-H)+ ions. Unfortunately, DME does not generate characteristic fragment ions indicative of the branch site. L. B. KJLLMER unpublished observation. Glycopeptides were quantitated by analytical RP-HPLC described in Fig. 2 .
Represents the kibdelins (-) and represents the aridicins (------). Eluants were as follows: A; 0.02 M phosphate (pH 7), B; 0.5 M NH4OAc (pH 7.8), C"E; 5% acetonitrile-H2O, F; 0.1 M ammonia containing 50% acetonitrile. A 600-liter fermentation was required to produce sufficient quantities of the novel antibiotics for subsequent purification and structural and biological analysed1). Although small-scale experiments revealed that pure preparations of kibdelin antibiotics can be made in a one-step affinity isolation procedure from clarified broth, a preliminary chromatography step on XAD-7 was added to preserve the life-time of the affinity support by removing impurities which tended to foul the column during loading. Clarification and XAD-7 chromatography yielded 5 g of the kidbelin antibiotics ( Table 1 ).
The yield of glycopeptides prior to affinity chromatography shows some variation due to the Sep-pak pretreatment.
Prior studies determined that elution of affinity-bound glycopeptides is highly dependent on their physical properties, in particular hydrophobicity and isoelectric point4>. The unusually low isoelectric point (3.8) of the aricidins results in their elution with combinations of acetonitrile and water in the absence of ammonia. However, vancomycin and ristocetin, which have isoelectric points of 8.2 and 8.4 respectively, require both high pH and organic modifier for good product recovery. Based on these observations, a differential elution procedure was used to separate the two types of glycopeptide complexes produced by the culture AAD-609 from the Affi-gel 10 -D-Ala-D-Ala support. After initial washings with phosphate and acetate buffers to remove non-specifically bound contaminants, 5 % acetonitrile effectively eluted the bound aridicins with less than 10% loss of the kibdelins (Fig. 1) . The latter were eluted in less than 2 column volumes using 50% acetonitrile in 0.1 M ammonia with high recovery (Table 1 ) and no detectable contamination by the aridicins. The HPLC profiles of the XAD-7 concentrate and the pooled acetonitrile -water and acetonitrile -ammonia eluates are shown in Fig. 2 . Because of the similarity in HPLC retention times of the kibdelins and aridicins the pre-fractionation of the two complexes by this selective desorption step greatly facilitated the subsequent fractionation by preparative HPLC. The methanol extract yielded an additional 3 g of The aridicin components were purified to homogeneity in order to firmly establish their identity.
Because the 600-liter fermentation had been optimized for novel component production", an earlier fermentation, where the aridicins predominated, was used for this purpose. Reversed-phase chromatography on Whatman ODS-3, desalting on XAD-7 and lyophilization, yielded each of the individual components in approximately 73 % yield. From 140 mg of affinity isolate was obtained the following: Aridicin A 59 mg, B 22 mg, C, 14 mg and C2 11 mg. Their identity was confirmed by comparison with authentic standards using HPLC with co-injection, UV spectra and E1% values in 0.1 m HCl and 0.1 N NaOH, production of pseudoaglycon by mild acid hydrolysis, fatty acid and carbohydrate content, pKa values, and molecular weight and fragmentation pattern by FAB-MS. In addition, the isoelectric point of the affinity purified aridicin complex was 3.8 as previously reported5). Purified kibdelin components were obtained by maximizing the sample load on the preparative reversed-phase column to 1.0-1.5 g per injection and pooling only the center portions of each of the resolved peaks (Fig. 3) . After desalting and lyophilization, the yields of purified components from 4.38 g of affinity-purified complex were A 550 mg, B 317 mg, C 315 mg and D 560 mg. components have identical UV spectra and exhibit a bathochromic shift from 280 nm, under neutral or acidic conditions, to 300 nm in base. The 1H NMR spectrum of kibdelin A at 500 MHz (Fig. 4) is representative of the glycopeptide antibiotics with signals attributable to protons associated with aromatic rings, carbohydrates, peptide and fatty acid moieties. The molecular weights of the parent glycopeptides were determined by FAB-MS11>. Aside from the m/z protonated molecular ion cluster, the most abundant ion in all four spectra occurs at 1,458 and is identical in mass to the mannosyl aglycon of the aridicin complex. This is in good agreement with results showing that mild acid hydrolysis converts each component of the complex to a single HPLC component which co-elutes on HPLC with authentic aridicin mannosyl aglycon. This data plus the presence of mannose (Table   2 ) and 7 titratable groups having the same pka values as those in the heptapeptide core of aridicin A (Table 3) 
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Since the kibdelins contain the mannosylated heptapeptide core common to the aridicins (and in the case of components A-C, the same fatty acid components), the aridicins and the kibdelins can only differ in the nature of the amino sugar component, which on the basis of mass differences in the two series, must be represented as a deoxyaminohexose. Characterization of this amino sugar as glucosamine was readily achieved by hydrolysis of kibdelin D in acid and subsequent treatment of the total acid hydrolysate sequentially with NaBH, and acetic anhydride to give a crude product containing the alditol-acetates5). The GC retention times of the two major components corresponded to the alditol-acetates of mannose and glucosamine. Furthermore, ions in the CI-MS spectra of the alditol-acetate products using ammonia as a reagent gas were also in agreement with the identification of these carbohydrates as mannose and glucosamine in that strong (M+NH4)+ ions were found at m/z 452 and 451, respectively.
While the foregoing evidence suggests that the kibdelins differ from the aridicins only in the oxidation level at the C-6 position of the amino sugar, firm proof was lacking that the glucosamine was N-acylated and that both the position of attachment and the stereochemistry of the glycosidic linkage to the heptapeptide core corresponded to that found in the aridicins. To establish these points, we (4)12) in the region of the sugar ring protons between 6 2.2-7.0. The similarity of the proton spectra of the two compounds derived from kibdelin D suggested that they differed only in configuration at C-1.
Unfortunately, assignment of the stereochemistry at this position although clearly suggested from the 1H NMR spectra could not be ascertained with certainty due primarily to lack of resolution in the spectrum of 312>. The use of 1H-13C one-bond coupling constants to determine the anomeric configuration of glycopyranosides may be made with confidence, whereas the use of 13C chemical shifts is somewhat less certain because of some overlap in the range of values found in compounds in the aand ~-anomer series14). The results of the study of the 13C spectra of compounds 2 and 3 are presented in Table 4 and constitute clear evidence for assigning the stereochemistry as the a-and 3-methyl glycosides, respectively.
The location of the acyl substituent on nitrogen was supported by the occurrence of an amide absorption at 1666 cm-1 in the FT-IR spectrum of the major product. Location of the position of the double bond in the N-acyl substituent in kibdelin D was accomplished by employing the method of The two remaining issues concerning the site and stereochemistry of attachment of the C-1 position of the N-acylglycopyranoside moiety to the heptapeptide nucleus of the mannosyl aglycon were subsequently resolved by the observation that 1'C-labelled kibdelins A-C serve as biosynthetic pre- 
